Recent studies have linked the elevated MMP9 enzyme levels with poor prognosis in breast cancer patients (Joseph et al., 2020), thus establishing an interesting correlation between the Hv1 channel upregulation, high levels of MMP9 expression in the breast cancer TME and poor survival in breast cancer patients. This evidence concerns the gene HVCN1 and breast carcinoma.